10.21147/j.issn.1000-9604.2022.05.05
Comments on National guidelines for diagnosis and treatment of prostate cancer 2022 in China(English version)
National guidelines for diagnosis and treatment of prostate cancer 2022 in China(English version)(1)was organized by the National Health Commission of the People's Republic of China,led by the Cancer Hospital of the Chinese Academy of Medical Sciences,and jointly compiled by well-known experts across China.On the basis of the 2018 version,the 2022 version of the guideline not only absorbs the updated content of the latest international guidelines,but also focuses on collecting some domestic evidence with a good level of evidence,and revises the relevant diagnosis and treatment recommendations to better adapt to domestic clinicians with different medical environment and resources.
national、prostate、english、cancer、china、comments、diagnosis、guidelines、treatment、version
34
S;H313;G2
2022-12-15(万方平台首次上网日期,不代表论文的发表时间)
共2页
456-457